U.S. Markets open in 2 hrs 34 mins

Strength Seen in Ohr Pharmaceutical, Inc. (OHRP) Stock Shoots 22%

Zacks Equity Research

Ohr Pharmaceutical, Inc. (OHRP) was a big mover last session, as the company saw its shares surge 22% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $13.34 to $16.44 in the past one-month time frame.

The company has seen 1 positive revision in the past month, while the Zacks Consensus Estimate of a loss narrowed over the same period, suggesting that more solid trading could be ahead for Ohr Pharmaceutical. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Ohr Pharmaceutical currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some other players in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.(CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

OHR PHARMACEUTICAL INC (OHRP): Free Stock Analysis Report


CAMBREX CORP (CBM): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

Zacks Investment Research